Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Metacrine Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Metacrine Inc market cap is $24.75M.
What is the 52-week high for Metacrine Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Metacrine Inc 52 week high is $0.5905 as of September 12, 2025.
What is the 52-week low for Metacrine Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Metacrine Inc 52 week low is $0.303 as of September 12, 2025.
What is Metacrine Inc stock price today?
Metacrine Inc stock price today is $0.0014.
What was Metacrine Inc stock price yesterday?
Metacrine Inc stock price yesterday was $0.589.
What is the PE ratio of Metacrine Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Metacrine Inc’s P/E ratio is -0.57.
What is the Price-to-Book ratio of Metacrine Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Metacrine Inc P/B ratio is 0.6677.
What is the 50-day moving average of Metacrine Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Metacrine Inc 50-day moving average is $0.5625.